Accumulating evidence indicates that SENP1 is involved in the desumoylation of androgen receptor (AR), and that overexpression of SENP1 increases AR transcriptional activity, which has been found in >50% of high-grade precancerous prostate tissues, and in numerous prostate cancer cases [3,7]. Here, AR is linked to prostate carcinoma.